Abstract
Mazindol, an indirect dopamine agonist, was given at 2 mg qd to 19 cocaine-dependent, methadone-tnaintainedpatients during a 2-week, placebo-controlled, crossover trial. Patients showed no significant reduction in cocaine use, but they had increased cocaine craving on mazindol compared with placebo.